Zoladex 10.8 mg contains the active ingredient Goserelin, which is a GnRH agonist (gonadotropin-releasing hormone agonist). It is used in the treatment of hormone-related conditions and certain types of cancer.
Indications:
Prostate cancer.
Breast cancer in premenopausal women.
Endometriosis.
Endometrial thinning prior to surgery.
Dosage Form:
Subcutaneous implant administered once every 12 weeks (3 months).
Warnings:
For use under medical supervision only.
May cause menopause-like symptoms.
Regular medical follow-up is required during treatment.
Reviews
There are no reviews yet.